tradmap

VNRX VOLITIONRX LTD

$1.47 +6.14%

Healthcare · In Vitro & In Vivo Diagnostic Substances

VOLITIONRX LTD (VNRX) is a healthcare company in the In Vitro & In Vivo Diagnostic Substances industry, with a market capitalization of $12 million. Shares last traded at $1.47, 54.8% below their 52-week high. Over the past year the stock is up 123.1%. Net profit margin is -1352.2%, below the peer median of -3.8%. Revenue grew 40.0% year over year.

Market Cap
$12M
Shares Out
8.3M
EPS (TTM)
$-2.38
P/E Ratio
P/S Ratio
7.09
P/B Ratio
Dividend / Share
Dividend Yield
52-Week High
$3.25
52-Week Low
$0.13
Volume
14,655
Avg Vol (3m)
72,324.81

Performance

1W
+7.30%
1M
-38.24%
3M
+666.02%
6M
+503.70%
YTD
+440.84%
1Y
+123.10%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
39.27
SMA (50)
$1.67
SMA (200)
$0.68
Price vs SMA50
-11.92%
Price vs SMA200
+116.51%
ATR (14)
$0.22

Financials

Revenue
$2M
Net Income
$-23M
Gross Margin
Operating Margin
-1258.5%
Net Margin
-1352.2%
Return on Equity
73.0%
Return on Assets
-258.5%
Current Ratio
0.33
Debt / Equity
-0.23
Revenue Growth (YoY)
+40.0%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

PeriodEPS (diluted)Reported
Q1 2026 $-0.97 2026-05-14
Q3 2025 $-0.17 2025-11-13
Q2 2025 $-0.12 2025-08-14
Q1 2026 $-1.12 2026-05-14
FY 2024 $-0.31 2025-03-31
Q3 2025 $-0.25 2025-11-13

Full earnings history →

In Vitro & In Vivo Diagnostic Substances peers

VNRX vs 14 industry peers (In Vitro & In Vivo Diagnostic Substances), by market cap.

P/S vs peers
7.09 / 4.39 med
+62% premium
Net margin vs peers
-1352.2% / -3.8% med
below median
1–14 of 14
IDXXIdexx Laboratories$44.3B41.8410.3024.6%+2.91%
LNTHLantheus Holdings, Inc.$6.8B28.974.3915.2%+0.67%
CLDXCelldex Therapeutics, Inc.$2.5B-9.84-1.47%
NTLAIntellia Therapeutics, Inc.$2.2B-5.30+2.25%
NEOGNeogen Corp$2.0B-1.85+4.14%
QDELQuidelortho Corp$932M+4.27%
ACHVAchieve Life Sciences, Inc.$496M-9.07-9.72%
MYGNMyriad Genetics Inc$429M-1.170.52-44.4%+3.65%
TKNOAlpha Teknova, Inc.$282M-16.326.95-42.6%+6.38%
IMDXInsight Molecular Diagnostics Inc.$176M-3510.5043.48-1.2%+2.25%
ICCCIMMUCELL CORP /DE/$86M-82.253.09-3.8%+0.53%
QCLSQ/C TECHNOLOGIES, INC.$32M-2.72+4.28%
VNRXVOLITIONRX LTD$12M-0.52+6.14%
CDIOCardio Diagnostics Holdings, Inc.$6M+2.53%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.